AI Ophthalmology and Optometry | Altris AI

AI for Diabetic Retinopathy

Book free trial to see how AI can detect DR and 70+ other pathologies/biomarkers

Book Intro AI Ophthalmology and Optometry | Altris AI

Altris AI is an AI Decision Support for OCT Analysis that leverages objective AI for Diabetic Retinopathy (DR) and its comprehensive progression monitoring.

Immediate detection of common DR biomarkers – Diffuse Edema, Subretinal fluid, Vitelliform material, Intraretinal hyperreflective foci, Microaneurysm, as well as less typical – Epiretinal fibrosis, Retinal wrinkling.

Objective measurement of individual DR biomarkers, with their locations visualized on ETDRS grids and B-scans.

Measurement and tracking of pathological DR signs over time to assess treatment response.

AI-powered analysis of Diabetic Retinopathy transforms raw information from OCT scans into structured, research-ready data.

Platform overview

Only practical features for eye care specialists and clinical research

GDPR compliant (all data is encrypted), CE-certified, and FDA- cleared (510k).

Alisdair Buchanan Clinical Director

As someone already confident in interpreting scans, I didn’t need help understanding OCT—but Altris AI provides something even more valuable: a kind of second opinion. It supports my clinical decisions and offers an added layer of reassurance, particularly in borderline or complex cases. That’s not just helpful—it’s powerful.

7 May, 2025

William C. Fruchtman, Optometry Owner

I was really excited to find Altris AI to bolster my skills identifying certain macular diseases. It's a great program and has guided me in the diagnosis of complex cases.

3 Oct, 2024

Scott Sedlacek Optometry Owner

Altris AI identified and described pathology that I could not. Early detection changes the treatment from doing nothing to something. Also, Altris AI described something that I thought was worse than it was. Saved me from over-referring. Patients love to see the color-coded images which help as an educational tool and get buy-in on the treatment plan which helps compliance.

1 Feb, 2024

Richard Clare Optometry Owner

We are adding a new OCT to one of our practices and may benefit from some extra support with AI to speed up the interpretation of results and assist the busy Optometry team.

Dec 7, 2023

Quickly and accurately track how DR is changing based on biomarker progression. Leverage automated comparisons of patient data from multiple visits through intuitive visualizations presented as percentages, maps, and graphs. Explore DR through Pathology Progression module to assess nanometer-level measurements of changes in biomarkers to determine the optimal treatment course confidently .

Accelerated workflow with immediate, automated DR biomarker identification.
Objective DR biomarkers measurements for precise trial actions.
Instant grasp of changes over time with intuitive visuals and a clear localization map.
Longitudinal data for more accurate Diabetic Retinopathy treatment assessment and planning.

Add OCT examinations from different visits

Detect all the biomarkers of DR with color-coding

Explore DR biomarkers in terms of area, volume

Track changes in DR biomarkers over time

How Altris AI works?

And what makes this AI the leading solution for Diabetic Retinopathy detection and management?

Altris AI is a web platform created by retina experts for all eye care specialists and clinicians.

We’ve collected millions of OCT scans, and our team graphically labeled thousands of them to create the Altris AI system that can:

Detect over 70 pathologies and biomarkers, including DR biomarkers.

Measure and track pathological changes across multiple examinations.

Monitor the progression of DR for better patient outcomes.

Get clinical insights with the help of objective measurements.

Formats

DICOM format will help you to extract maximum information. However, the system works with all
data formats, such as jpg, and png

OCT equipment

Altris AI is vendor-neutral. We work with all the OCT equipment producers

OCT reports

We create comprehensible OCT reports for patients and doctors

For Clinical Research

What you get with Altris AI:

Accelerate ophthalmic drug trial with AI
Detect DR and its biomarkers ( +70 retinal pathologies and biomarkers) with AI
Track the progression of biomarkers to assess drug efficiency
Enroll the right patients based on fast biomarkers detection
Reduce costs associated with manual scan review with automated analysis
Reduce human made errors to the minimum

For Eye Care

We support you through the whole way

14 Days of Free Trial to see the value
Support during the whole trial period
Early glaucoma assessment module access
CE-certified, GDPR, HIPAA compliant, FDA clearance
Integration support with any EHR, EMR system.
Cloud data storage/on premises possible
Access to the whole functional during trial

Contact us

Ask us any question

For a clinic or an optometry: we will show the system to you during 15-minute call and then you will have a free trial to test it yourself.

Book intro + free trial

Any eye care practitioner can test it for a personal use for free

Demo